ACP-103 to Treat Parkinson's Disease

NCT00086294 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Parkinson's Disease
Dyskinesias

Interventions

DRUG: Intravenous Levodopa
DRUG: ACP-103

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)